Thus, SFRP5 levels could be used to separate HF from non-HF patients in a heterogeneous cohort of CVD patients confirming that it may be suitable for diagnostic as well as risk stratification purposes in HF patients [16]. The gene discussed is SFRP5; the disease is hydrops fetalis.